West Pharmaceutical Services Inc recorded an increase in cost of sales by 10.39 % year on year, relative to one quarter ago cost of sales fell by -0.89 % in Q2.
West Pharmaceutical Services Inc recorded increase in cost of sales by 10.39 % year on year, compare to one quarter ago cost of sales fell by -0.89 % in Q2.
West Pharmaceutical Services Inc's Comment on Supply Chain
We use three basic raw materials in the manufacture of our products: elastomers,
aluminum and plastic. Elastomers include both natural and synthetic materials.
We currently have access to adequate supplies of these raw materials to meet our
production needs through agreements with suppliers.
We employ a supply chain management strategy in our business segments, which involves
purchasing from integrated suppliers that control their own sources of supply.
Due to regulatory control over our production processes, and the cost and time
involved in qualifying suppliers, we rely on single-source suppliers for many
critical raw materials. We purchase certain raw materials in the open market.
This strategy increases the risk that our supply chain may be interrupted in the
event of a supplier production problem. These risks are managed, where possible,
by selecting suppliers with multiple manufacturing sites, rigorous quality control
systems, surplus inventory levels and other methods of maintaining supply in case
of an interruption in production.
West Pharmaceutical Services Inc's Comment on Supply Chain
We use three basic raw materials in the manufacture of our products: elastomers,
aluminum and plastic. Elastomers include both natural and synthetic materials.
We currently have access to adequate supplies of these raw materials to meet our
production needs through agreements with suppliers.
We employ a supply chain management strategy in our business segments, which involves
purchasing from integrated suppliers that control their own sources of supply.
Due to regulatory control over our production processes, and the cost and time
involved in qualifying suppliers, we rely on single-source suppliers for many
critical raw materials. We purchase certain raw materials in the open market.
This strategy increases the risk that our supply chain may be interrupted in the
event of a supplier production problem. These risks are managed, where possible,
by selecting suppliers with multiple manufacturing sites, rigorous quality control
systems, surplus inventory levels and other methods of maintaining supply in case
of an interruption in production.
Sources:
West Pharmaceutical Services Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on West Pharmaceutical Services Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
